{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T01:14:21Z","timestamp":1783300461032,"version":"3.54.6"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51797-0","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:45:24Z","timestamp":1777956324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ASO-functionalized gold nanoparticles for gene silencing in drug-resistant Pseudomonas aeruginosa: a proof-of-concept study"],"prefix":"10.1038","volume":"16","author":[{"given":"Sarah Najah","family":"AlJanabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maroua","family":"Gdoura-Ben Amor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wathiq Abbas","family":"Al-Draghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanen","family":"Sellami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfa","family":"Frikha-Gargouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"issue":"18","key":"51797_CR1","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s40265-021-01635-6","volume":"81","author":"D Reynolds","year":"2021","unstructured":"Reynolds, D. & Kollef, M. The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update. Drugs 81 (18), 2117\u20132131. https:\/\/doi.org\/10.1007\/s40265-021-01635-6 (2021).","journal-title":"Drugs"},{"issue":"1","key":"51797_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","volume":"37","author":"Z Pang","year":"2019","unstructured":"Pang, Z., Raudonis, R., Glick, B. R., Lin, T. J. & Cheng, Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol. Adv. 37 (1), 177\u2013192 (2019).","journal-title":"Biotechnol. Adv."},{"issue":"1","key":"51797_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12879-021-05883-5","volume":"21","author":"A Litwin","year":"2021","unstructured":"Litwin, A., Rojek, S., Gozdzik, W. & Duszynska, W. Pseudomonas aeruginosa device associated \u2013 healthcare associated infections and its multidrug resistance at intensive care unit of University Hospital: Polish, 8.5-Year, Prospective, Single-Centre Study. BMC Infect. Dis. 21 (1), 180. https:\/\/doi.org\/10.1186\/s12879-021-05883-5 (2021).","journal-title":"BMC Infect. Dis."},{"key":"51797_CR4","doi-asserted-by":"publisher","first-page":"100640","DOI":"10.1016\/j.drup.2019.07.002","volume":"44","author":"J Botelho","year":"2019","unstructured":"Botelho, J., Grosso, F. & Peixe, L. Antibiotic resistance in Pseudomonas aeruginosa\u2013mechanisms, epidemiology and evolution. Drug Resist. Updat. 44, 100640 (2019).","journal-title":"Drug Resist. Updat"},{"key":"51797_CR5","doi-asserted-by":"publisher","first-page":"823684","DOI":"10.3389\/fcimb.2022.823684","volume":"12","author":"SS Jean","year":"2022","unstructured":"Jean, S. S., Harnod, D. & Hsueh, P. R. Global threat of carbapenem-resistant gram-negative bacteria. Front. Cell. Infect. Microbiol. 12, 823684 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"9","key":"51797_CR6","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/microorganisms11092211","volume":"11","author":"RL Co\u0219eriu","year":"2023","unstructured":"Co\u0219eriu, R. L. et al. Uncovering the resistance mechanisms in extended-drug-resistant Pseudomonas aeruginosa clinical isolates: insights from gene expression and phenotypic tests. Microorganisms 11 (9), 2211 (2023).","journal-title":"Microorganisms"},{"issue":"3","key":"51797_CR7","doi-asserted-by":"publisher","first-page":"e00202","DOI":"10.1128\/mSphere.00202-21","volume":"6","author":"M Al-Orphaly","year":"2021","unstructured":"Al-Orphaly, M. et al. Epidemiology of multidrug-resistant Pseudomonas aeruginosa in the Middle East and North Africa Region. mSphere 6 (3), e00202\u2013e00221. https:\/\/doi.org\/10.1128\/mSphere.00202-21 (2021).","journal-title":"mSphere"},{"issue":"Suppl 1","key":"51797_CR8","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.4103\/mjbl.mjbl_228_23","volume":"21","author":"MA Oudah","year":"2024","unstructured":"Oudah, M. A. Antibiotic resistance profile of pathogenic bacteria isolated from healthcare rooms in the Mosul Government Hospital, Iraq. Med. J. Babylon. 21 (Suppl 1), S70\u2013S80 (2024).","journal-title":"Med. J. Babylon."},{"key":"51797_CR9","doi-asserted-by":"publisher","first-page":"100661","DOI":"10.1016\/j.nmni.2020.100661","volume":"35","author":"MK Alkhudhairy","year":"2020","unstructured":"Alkhudhairy, M. K. & Al-Shammari, M. M. M. Prevalence of Metallo-\u03b2-Lactamase\u2013producing Pseudomonas aeruginosa isolated from diabetic foot infections in Iraq. New. Microbes New. Infect. 35, 100661 (2020).","journal-title":"New. Microbes New. Infect."},{"issue":"2","key":"51797_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/MJBL.MJBL_24_20","volume":"17","author":"ST Baban","year":"2020","unstructured":"Baban, S. T. Molecular detection of carbapenemase-producing Pseudomonas aeruginosa isolated from intensive care units of surgical specialty Hospital in Erbil City. Med. J. Babylon. 17 (2), 185\u2013193 (2020).","journal-title":"Med. J. Babylon."},{"issue":"22","key":"51797_CR11","doi-asserted-by":"publisher","first-page":"8671","DOI":"10.3390\/ijms21228671","volume":"21","author":"MTT Thi","year":"2020","unstructured":"Thi, M. T. T., Wibowo, D. & Rehm, B. H. Pseudomonas aeruginosa Biofilms. Int. J. Mol. Sci. 21 (22), 8671 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"51797_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/antibiotics10010003","volume":"10","author":"C Uru\u00e9n","year":"2020","unstructured":"Uru\u00e9n, C., Chopo-Escuin, G., Tommassen, J., Mainar-Jaime, R. C. & Arenas, J. Biofilms as promoters of bacterial antibiotic resistance and tolerance. Antibiotics 10 (1), 3 (2020).","journal-title":"Antibiotics"},{"key":"51797_CR13","doi-asserted-by":"crossref","unstructured":"Chatterjee, S., Bhattacharya, M., Lee, S. S. & Chakraborty, C. An insight of different classes of rna-based therapeutic, nanodelivery and clinical status: current landscape. Curr Res. Biotechnol 100150. 6 (2023).","DOI":"10.1016\/j.crbiot.2023.100150"},{"issue":"3","key":"51797_CR14","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.nano.2017.12.026","volume":"14","author":"XY Xue","year":"2018","unstructured":"Xue, X. Y. et al. Advances in the delivery of antisense oligonucleotides for combating bacterial infectious diseases. Nanomed. Nanotechnol Biol. Med. 14 (3), 745\u2013758. https:\/\/doi.org\/10.1016\/j.nano.2017.12.026 (2018).","journal-title":"Nanomed. Nanotechnol Biol. Med."},{"key":"51797_CR15","doi-asserted-by":"crossref","unstructured":"Walia, S. & Mehta, M. J. Recent progress on nanosystems for nucleic acid delivery. RSC Pharm 1(4), 645-674 (2024).","DOI":"10.1039\/D4PM00009A"},{"issue":"1","key":"51797_CR16","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12951-024-02733-9","volume":"22","author":"J Qi","year":"2024","unstructured":"Qi, J. et al. Rational design of ROS scavenging and fluorescent gold nanoparticles to deliver siRNA to improve plant resistance to Pseudomonas syringae. J. Nanobiotechnol. 22 (1), 446 (2024).","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"51797_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12951-016-0202-0","volume":"14","author":"Y He","year":"2016","unstructured":"He, Y. et al. Study on the mechanism of antibacterial action of magnesium oxide nanoparticles against foodborne pathogens. J. Nanobiotechnol. 14 (1), 54. https:\/\/doi.org\/10.1186\/s12951-016-0202-0 (2016).","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"51797_CR18","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3 (6), 1101\u20131108 (2008).","journal-title":"Nat. Protoc."},{"key":"51797_CR19","doi-asserted-by":"crossref","unstructured":"Heidari, Z., Mardaneh, J., Sharifi, A., Gharaghani, M. & Jafari, Z. Prevalence of drug resistance and pathogenic factors of Pseudomonas aeruginosa isolates recovered from hospitalized patients. Jundishapur J. Microbiol 17 (8). (2024).","DOI":"10.5812\/jjm-149213"},{"issue":"08","key":"51797_CR20","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3855\/jidc.18400","volume":"18","author":"VF de Almeida","year":"2024","unstructured":"de Almeida, V. F. et al. Relationship between antimicrobial use and the highest number of multidrug-resistant-Pseudomonas aeruginosa: a 10-year study. J. Infect. Dev. Ctries. 18 (08), 1227\u20131232 (2024).","journal-title":"J. Infect. Dev. Ctries."},{"key":"51797_CR21","doi-asserted-by":"publisher","unstructured":"Matlock, W., Shaw, L. P. & Stoesser, N. Global genomic epidemiology of Bla GES\u20135 carbapenemase-associated integrons. Microb. Genomics. 10 (12). https:\/\/doi.org\/10.1099\/mgen.0.001312 (2024).","DOI":"10.1099\/mgen.0.001312"},{"issue":"1","key":"51797_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1128\/AAC.50.1","volume":"50","author":"V Aloush","year":"2006","unstructured":"Aloush, V., Navon-Venezia, S., Seigman-Igra, Y., Cabili, S. & Carmeli, Y. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob. Agents Chemother. 50 (1), 43\u201348. https:\/\/doi.org\/10.1128\/AAC.50.1 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"23","key":"51797_CR23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.5897\/AJMR2016.8042","volume":"10","author":"JR Al-Zaidi","year":"2016","unstructured":"Al-Zaidi, J. R. Antibiotic susceptibility patterns of Pseudomonas aeruginosa isolated from clinical and hospital environmental samples in Nasiriyah, Iraq. Afr. J. Microbiol. Res. 10 (23), 844\u2013849 (2016).","journal-title":"Afr. J. Microbiol. Res."},{"issue":"3","key":"51797_CR24","first-page":"90","volume":"2","author":"Z Aminizadeh","year":"2011","unstructured":"Aminizadeh, Z. & Kashi, M. S. Prevalence of multi-drug resistance and pandrug resistance among multiple gram-negative species: experience in one teaching hospital, Tehran, Iran. Int. Res. J. Microbiol. 2 (3), 90\u201395 (2011).","journal-title":"Int. Res. J. Microbiol."},{"key":"51797_CR25","doi-asserted-by":"crossref","unstructured":"Mansour, S. A., Eldaly, O., Jiman Fatani, A., Mohamed, M. L. & Ibrahim, E. M. Epidemiological characterization of P. aeruginosa isolates of intensive care units in Egypt and Saudi Arabia. EMHJ-East. Mediterr. Health J. 19(1), 71\u201380 (2013).","DOI":"10.26719\/2013.19.1.71"},{"issue":"3","key":"51797_CR26","first-page":"073","volume":"12","author":"R Mousa","year":"2022","unstructured":"Mousa, R., El-Kady, M. F., Hussein, A. A., Ahmed, A. E. & El-Gendy, A. O. Occurrence of carbapenem multidrug-resistant Pseudomonas aeruginosa carrying blaVIM Metallo-\u00df-Lactamases and their biofilm phenotypes in Al-Azhar University Hospital. J. Appl. Pharm. Sci. 12 (3), 073\u2013081 (2022).","journal-title":"J. Appl. Pharm. Sci."},{"key":"51797_CR27","first-page":"39","volume":"2","author":"M Wassef","year":"2015","unstructured":"Wassef, M., Mahallawy, H. E., Zafer, M. M., Ghaith, D. & Hamid, R. A. Lab based surveillance of multidrug resistant Pseudomonas aeruginosa in Cairo University Hospitals. Egypt. J. Microbiol. Exp. 2, 39\u201343 (2015).","journal-title":"Egypt. J. Microbiol. Exp."},{"issue":"1","key":"51797_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.11599\/germs.2016.1087","volume":"6","author":"H Vaez","year":"2016","unstructured":"Vaez, H. & Beigi, F. Antibiotic susceptibility patterns of aerobic bacterial strains isolated from patients with burn wound infections. Germs 6 (1), 34 (2016).","journal-title":"Germs"},{"issue":"1","key":"51797_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.36103\/ijas.v54i1.1679","volume":"54","author":"MK Khudhair","year":"2023","unstructured":"Khudhair, M. K. & AlAubydi, M. A. Determination the prevalence and antimicrobial susceptibility of bacteria isolated from burns and wounds. Iraqi J. Agric. Sci. 54 (1), 93\u201399 (2023).","journal-title":"Iraqi J. Agric. Sci."},{"issue":"8","key":"51797_CR30","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1128\/AAC.00540-16","volume":"60","author":"M Castanheira","year":"2016","unstructured":"Castanheira, M., Mendes, R. E., Jones, R. N. & Sader, H. S. Changes in the frequencies of \u03b2-lactamase genes among enterobacteriaceae isolates in U.S. Hospitals, 2012 to 2014: activity of ceftazidime-avibactam tested against \u03b2-lactamase-producing isolates. Antimicrob. Agents Chemother. 60 (8), 4770\u20134777. https:\/\/doi.org\/10.1128\/AAC.00540-16 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"51797_CR31","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1093\/cid\/ciaa1478","volume":"72","author":"PD Tamma","year":"2021","unstructured":"Tamma, P. D. et al. Infectious Diseases Society of America Guidance on the treatment of extended-spectrum \u03b2-lactamase producing enterobacterales (ESBL-E), carbapenem-resistant enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Clin. Infect. Dis. 72 (7), e169\u2013e183 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"51797_CR32","unstructured":"Alsaadi, L. A. S., Rasheed Al-Taai, H. R. & Al-Dulaimi, A. A. F. Effects of zinc oxide nanoparticles and ceftazidime on the gene expression of extended spectrum b-lactamase (bla oxa\u201310) of Pseudomonas aeruginosa in diyala, Iraq. Biochem Cell. Arch 20 (1). (2020)."},{"issue":"1","key":"51797_CR33","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3892\/mmr.2014.2685","volume":"11","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. Characterization by phenotypic and genotypic methods of metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa isolated from patients with cystic fibrosis. Mol. Med. Rep. 11 (1), 494\u2013498. https:\/\/doi.org\/10.3892\/mmr.2014.2685 (2015).","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"51797_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.5604\/01.3001.0010.4855","volume":"66","author":"AF Abaza","year":"2017","unstructured":"Abaza, A. F., El Shazly, S. A., Selim, H. S. A. & Aly, G. S. A. Metallo-Beta-lactamase producing Pseudomonas aeruginosa in a healthcare setting in Alexandria, Egypt. Pol. J. Microbiol. 66 (3), 297\u2013308. https:\/\/doi.org\/10.5604\/01.3001.0010.4855 (2017).","journal-title":"Pol. J. Microbiol."},{"issue":"30","key":"51797_CR35","first-page":"5528","volume":"5","author":"MH Al-Agamy","year":"2011","unstructured":"Al-Agamy, M. H., Shibl, A. M., Zaki, S. A. & Tawfik, A. F. Antimicrobial resistance pattern and prevalence of Metallo-\u03b2-lactamases in Pseudomonas aeruginosa from Saudi Arabia. Afr. J. Microbiol. Res. 5 (30), 5528\u20135533 (2011).","journal-title":"Afr. J. Microbiol. Res."},{"key":"51797_CR36","doi-asserted-by":"crossref","unstructured":"Zolfaghari, M. R. Detection of BlaVIM and BlaIMP carbapenemase-producing Pseudomonas aeruginosa from clinical samples in Iran. Int J. Med. Lab 8(3), 180-187 (2021).","DOI":"10.18502\/ijml.v8i3.7324"},{"issue":"Supplement_7","key":"51797_CR37","doi-asserted-by":"publisher","first-page":"S521","DOI":"10.1093\/cid\/ciz824","volume":"69","author":"P Nordmann","year":"2019","unstructured":"Nordmann, P. & Poirel, L. Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria. Clin. Infect. Dis. 69 (Supplement_7), S521\u2013S528 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"51797_CR38","doi-asserted-by":"crossref","unstructured":"Li, J. et al. Trends and implications of antimicrobial resistance in Pseudomonas aeruginosa: insights from a 19-year study in Zhejiang Province. Medicine (Baltimore). 103 (46), e40606. (2024).","DOI":"10.1097\/MD.0000000000040606"},{"issue":"2","key":"51797_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.kjms.2017.09.010","volume":"34","author":"N Murugan","year":"2018","unstructured":"Murugan, N., Malathi, J., Therese, K. L. & Madhavan, H. N. Application of six multiplex PCR\u2019s among 200 clinical isolates of Pseudomonas aeruginosa for the detection of 20 drug resistance encoding genes. Kaohsiung J. Med. Sci. 34 (2), 79\u201388 (2018).","journal-title":"Kaohsiung J. Med. Sci."},{"key":"51797_CR40","doi-asserted-by":"publisher","first-page":"101301","DOI":"10.1016\/j.genrep.2021.101301","volume":"24","author":"M Abavisani","year":"2021","unstructured":"Abavisani, M. et al. Evaluation of efflux pumps overexpression and \u03b2-lactamase genes among colistin resistant Pseudomonas aeruginosa. Gene Rep. 24, 101301 (2021).","journal-title":"Gene Rep."},{"issue":"2","key":"51797_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jgar.2015.04.002","volume":"3","author":"R Galetti","year":"2015","unstructured":"Galetti, R., Andrade, L. N. & da Darini, C. Pseudomonas aeruginosa carrying Bla CTX-M\u20132 in Brazil: the occurrence of \u2018high-risk clones\u2019? J. Glob Antimicrob. Resist. 3 (2), 153\u2013154 (2015).","journal-title":"J. Glob Antimicrob. Resist."},{"issue":"11","key":"51797_CR42","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.4314\/tjpr.v17i11.17","volume":"17","author":"X Yang","year":"2018","unstructured":"Yang, X. et al. Identification of multi-drug resistant genes in P. aeruginosa isolates from patients under mechanical ventilation and respiratory support in an intensive care unit. Trop. J. Pharm. Res. 17 (11), 2227\u20132234 (2018).","journal-title":"Trop. J. Pharm. Res."},{"issue":"4","key":"51797_CR43","first-page":"153","volume":"4","author":"TF Alan","year":"2016","unstructured":"Alan, T. F. et al. Detection of blaNDM, blaDIM, blaIMP, blaVIM and blaCTX-M\u201315 beta-lactamase genes among Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from two hospitals of Tehran, Iran. Nov Biomed. 4 (4), 153\u2013158 (2016).","journal-title":"Nov Biomed."},{"issue":"4","key":"51797_CR44","first-page":"781","volume":"2","author":"AL Abdallah","year":"2021","unstructured":"Abdallah, A. L., El Azawy, D. S., Mohammed, H. A. & El Maghraby, H. M. Expression of Mex AB-Opr M Efflux pump system and meropenem resistance in Pseudomonas aeruginosa isolated from surgical intensive care unit. Microbes Infect. Dis. 2 (4), 781\u2013789 (2021).","journal-title":"Microbes Infect. Dis."},{"issue":"3","key":"51797_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/microbiolres16030070","volume":"16","author":"CR Garza-Cardenas","year":"2025","unstructured":"Garza-Cardenas, C. R., Leon-Buitimea, A., Siller-Ceniceros, A. A. & Morones-Ramirez, J. R. Antisense oligonucleotide-capped gold nanoparticles as a potential strategy for tackling antimicrobial resistance. Microbiol. Res. 16 (3), 70 (2025).","journal-title":"Microbiol. Res."},{"issue":"3","key":"51797_CR46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1574-695X.2010.00742.x","volume":"60","author":"H Wang","year":"2010","unstructured":"Wang, H. et al. oprM as a new target for reversion of multidrug resistance in Pseudomonas aeruginosa by antisense phosphorothioate oligodeoxynucleotides. FEMS Immunol. Med. Microbiol. 60 (3), 275\u2013282 (2010).","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"6","key":"51797_CR47","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.51248\/.v43i6.3718","volume":"43","author":"FM Al-Qurashi","year":"2023","unstructured":"Al-Qurashi, F. M. & Al-Draghi, W. A. Detection of the effect of synthetic siRNA on Efflux pump MexA gene expression and antibiotic resistance in clinical isolates of Pseudomonas aeruginosa. Biomedicine 43 (6), 1807\u20131812 (2023).","journal-title":"Biomedicine"},{"issue":"3","key":"51797_CR48","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ja.2014.132","volume":"68","author":"J Meng","year":"2015","unstructured":"Meng, J. et al. Reversion of antibiotic resistance by inhibiting meca in clinical methicillin-resistant staphylococci by antisense phosphorothioate oligonucleotide. J. Antibiot. (Tokyo). 68 (3), 158\u2013164 (2015).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"51797_CR49","doi-asserted-by":"crossref","unstructured":"Bai, B., Ren, J., Bai, F. & Hao, L. Selection and validation of reference genes for gene expression studies in Pseudomonas brassicacearum GS20 using real-time quantitative reverse transcription PCR. PLoS One 15 (1), e0227927. (2020).","DOI":"10.1371\/journal.pone.0227927"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51797-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51797-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51797-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:17:45Z","timestamp":1783297065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51797-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51797"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51797-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Baghdad University\/Institute of Genetic Engineering and Biological Technologies for Graduate Studies (protocol code 1001 and date of approval 02\u221209\u22122021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patient(s) to publish this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"20623"}}